Dr. Amelie Carola Tiritilli, MD

Dr. Tiritilli practices at Gastroenterology South - Oregon City in Oregon City, Oregon.

Dr. Tiritilli's NPI, 1962908061, was assigned on April 5, 2018. Dr. Tiritilli graduated from University of Colorado School of Medicine, Aurora in 2018. Dr. Tiritilli holds Montana license MED-PHYS-LIC-141294.

Dr. Tiritilli's primary practice is Gastroenterology South - Oregon City, at 1508 Division St, Oregon City, OR 97045 in Clackamas County. The practice phone is (503) 692-3750.

Dr. Tiritilli's primary practice is Gastroenterology South - Oregon City in Oregon City, Oregon. Dr. Tiritilli is also affiliated with Providence Willamette Falls Medical Center. The medical group on file is The Oregon Clinic. Dmand AI also links Dr. Tiritilli to 4 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tiritilli practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tiritilli's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tiritilli is licensed in Montana.

CMS data shows 135 Medicare services from Dr. Tiritilli across 3 procedure codes in 2024, for 136 Medicare patients. Medicare paid $17,662 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 136 Medicare patients who saw Dr. Tiritilli in 2024. The largest group is 65 to 74, with 91 patients. 60% of them have high blood pressure, and 57% have high cholesterol. 10% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tiritilli's median patient age at 58, with 62% women.

In 2024, Dr. Tiritilli wrote 81 Medicare Part D claims for 68 patients. 77% of them were for generic drugs. CMS names the drug for 56 of them, across 2 drugs with 11 or more claims each, at $1,271 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Tiritilli for performance year 2024, reported as part of a group. Dr. Tiritilli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tiritilli as offering telehealth. CMS counts 71 procedures of colonoscopy by Dr. Tiritilli, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Tiritilli, published from 2021 to 2022. The most frequent topics are Colorectal Neoplasms. Dr. Tiritilli's most frequent co-authors are Marc Monachese, Zain Moosvi, MD and Ronald Ortizo.

CMS Open Payments shows 10 general payments to Dr. Tiritilli from 9 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Intercept Pharmaceuticals, Inc. paid the most, $238.

Dr. Tiritilli graduated from University of Colorado School of Medicine, Aurora in 2018.